Alina Costina Luca, Ingrith Crenguţa Miron, Laura Mihaela Trandafir, Elena Cojocaru, Ioana Alexandra Pădureţ, Mioara Florentina Trandafirescu, Alin Constantin Iordache, Elena Ţarcă
Infantile hemangiomas (IHs) are the most frequent pediatric benign vascular tumors, with a reported incidence of 5% to 10%. They have self-limiting evolution pattern divided into a growth phase in the first 12 months and a regression one, that may take up to 10 years. Occasionally, hemangiomas might lead to local or systemic complications, depending on their morphological characteristics. The first line of treatment is β-blockers, such as Propranolol, Timolol, Nadolol, administered either locally or systemically...
July 2020: Romanian Journal of Morphology and Embryology